Viewing Study NCT00697632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:01 PM
Ignite Modification Date: 2026-01-18 @ 7:58 PM
Study NCT ID: NCT00697632
Status: COMPLETED
Last Update Posted: 2019-02-12
First Post: 2008-05-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Sponsor: Mirati Therapeutics Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MET View
None AXL View
None VEGFR View
None NSCLC View
None HNSCC (Head and neck squamous cell carcinoma) View
None Tumor View
None Safety View
None Phase 1 View
None Solid tumor View